Background. HCV testing and linkage to care directly impact treatment effectiveness. Sexually transmitted disease (STD) clinics serve populations at high risk for HCV. We describe experience with HCV testing and linkage to care at public STD clinics in Baltimore.
years, 92% African American, 61% male were screened for hepatitis C. Overall, 142(6.4%) were HCV antibody positive. 108 (76%) of patients were insured; majority through Medicaid (56.5%). All these patients had previously accessed care at the STD clinics. Among 326 patients born between 1945 and 1965 (the CDC "birth cohort"), 28% were HCV antibody positive. Of the 142 HCV positive patients, 98% had confirmatory HCV RNA testing; of which 115 (82.7%) were confirmed to be viremic. Of the 115 HCV RNA positive patients, 80% returned to the STD clinic for initiation of HCV care and referral to a specialist; however, only 33% of patients attended an HCV specialist appointment. 70% of patients who have not accessed specialist care have been seen at the STD clinics 2 or more times since a diagnosis of HCV.
Conclusion. We identified a high prevalence of HCV infection in the BCHD STD clinics. Despite continuing to access care and patient navigation services at the STD clinic, attendance at specialist HCV appointments have remained low. As HCV treatments become simpler and more tolerable, STD clinics have the potential to serve as HCV treatment sites.
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